HeldP.J., PortF.K., WebbR.L.Excerpts from United States Renal Data System 1991. Annual data report.Am J Kidney Dis1991; 18(Suppl 2): 1–127.
2.
MaK.W., GreeneE.L., RaijL.Cardiovascular risk factors in chronic renal failure and hemodialysis populations.Am J Kidney Dis1992; 19: 505–13.
3.
RottembourgJ.B.CAPD is more advantageous than hemodialysis.Semin Dial1992; 5: 212–4.
4.
LameireN., MatthysD., MatthysE.Effects of long-term CAPD on carbohydrate and lipid metabolism.Clin Nephrol1988; 30(Suppl 1): S53–8.
5.
Di PaoloB., Del RossoG., CatucciG.Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.ASAIO Trans1990; 36: M578–80.
6.
ChanM.K.Cemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: The role of postheparin lipases in the metabolism of high -density lipoprotein subfractions.Metabolism1989; 38: 939–45.
7.
JonesR.G., DibbleJ.B., GibsonJ.Effect of dietary fish oil on lipid abnormalities in patients on continuous ambulatory peritoneal dialysis.Perit Dial Int1988; 8: 203–6.
8.
MatthysE., SchurgersM., LamberigtsG.Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.Atherosclerosis1991; 86: 183–92.
